Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein.
about
Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.Modification of the mycobacteriophage Ms6 attP core allows the integration of multiple vectors into different tRNAala T-loops in slow- and fast-growing mycobacteria.Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag.Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model.Plasmidic versus insertional cloning of heterologous genes in Mycobacterium bovis BCG: impact on in vivo antigen persistence and immune responsesIntracellular bacteria as targets and carriers for vaccination.Recombinant BCG as a vaccine vehicle to protect against tuberculosis.Secretion of human interleukin 2 by recombinant Mycobacterium bovis BCG.Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strainsGenetic control of antibody responses induced by recombinant Mycobacterium bovis BCG expressing a foreign antigenIdentification of mycobacterium tuberculosis DNA sequences encoding exported proteins by using phoA gene fusionsLeprosy, tuberculosis, and the new genetics.Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.Characterization of the gene encoding the immunodominant 35 kDa protein of Mycobacterium leprae.Progress towards an HIV vaccine based on recombinant bacillus Calmette-Guérin: failures and challenges.Escherichia coli-mycobacteria shuttle vectors for operon and gene fusions to lacZ: the pJEM series.Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin.Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T-lymphocyte responses in mice.The uraA locus and homologous recombination in Mycobacterium bovis BCG.A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.Mycobacterium bovis BCG priming induces a strong potentiation of the antibody response induced by recombinant BCG expressing a foreign antigen.Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis.Bilateral, Misalignment-Compensating, Full-DOF Hip Exoskeleton: Design and Kinematic Validation.Molecular characterization of heterologous HIV-1gp120 gene expression disruption in mycobacterium bovis BCG host strain: a critical issue for engineering mycobacterial based-vaccine vectors.Expression of Escherichia coli beta-galactosidase in Mycobacterium bovis BCG using an expression system isolated from Mycobacterium paratuberculosis which induced humoral and cellular immune responses.Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitum beta-lactamase genes cloned from a natural isolate and a high-level beta-lactamase producer.rpsL+: a dominant selectable marker for gene replacement in mycobacteria.
P2860
Q30387447-12CC29BA-AF2A-4474-AC33-A1FC069D41A0Q33266831-EA76FE60-7975-4814-81ED-C30B02107C6CQ33596979-03313330-9F37-400D-8C20-BCD3C95F1BD2Q33883995-4738FC31-CE49-4A2D-AFBD-DE5DE1CC31BFQ34007536-C04DFE31-56F7-4ED6-B976-67A5BEFB5A55Q34116296-1B5ADCC8-2C2E-4AD3-BFDD-3B3861AA9AF4Q34280918-7846CBF6-F5DD-46A3-93FC-77EA4BC6D99FQ34518560-2DBFA44F-E0C6-4BF5-82C9-8280D158B141Q35390742-C0EFE40E-DC8D-40A7-B592-699C3592C77BQ35460181-B7127961-F436-4509-A141-D7A3A7747C71Q35552033-9F351A73-5709-44B9-B49F-C2A388A2CD1CQ35576276-7DE0D6DC-37C9-4D3A-BA0B-35AAC4819917Q35965717-83460595-D2DB-4606-AC37-8FAD97CF0ED5Q36404193-9703FEC9-475D-4B41-9D6C-9F7AF44C7379Q36669671-AE2BDEE9-915C-4A87-8CC3-5734CEA7BE36Q36690291-53A2ADCC-95AA-4FF7-AA81-E04846212AF4Q36726944-D1314E4F-B6D3-42E7-995A-789DF012FF6EQ39518278-8E9D33BA-CEE7-4137-AE74-54C0FF60D49FQ39878736-1CD95211-C2B2-4AD1-A8D1-066CAB57C076Q39937762-4F2B112A-D0DD-4CCC-BB12-70AE68641658Q40109570-D3518A36-28C4-4FF5-BCCC-721DEDEAAC89Q40375560-927B660C-7C5C-4731-AFF8-74A4D3F7CCA9Q40376405-A880D92A-B75A-4470-9512-A35801843367Q41169073-EF11B467-0193-43FC-B181-0C0A23A0B7F3Q42165676-F8B973C3-9045-434C-AF0C-C5272B227356Q42600866-3D649115-05CE-4A07-BCBC-F630DF4E48C6Q48082913-88EDFC9B-C331-43AE-BE6A-578DD70313F7Q54172358-EC9E06B6-E8AA-4FD6-8882-41CAF01225BC
P2860
Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Expression of heterologous gen ...... nse against HIV-1 Nef protein.
@en
Expression of heterologous gen ...... nse against HIV-1 Nef protein.
@nl
type
label
Expression of heterologous gen ...... nse against HIV-1 Nef protein.
@en
Expression of heterologous gen ...... nse against HIV-1 Nef protein.
@nl
prefLabel
Expression of heterologous gen ...... nse against HIV-1 Nef protein.
@en
Expression of heterologous gen ...... nse against HIV-1 Nef protein.
@nl
P2093
P1433
P1476
Expression of heterologous gen ...... nse against HIV-1 Nef protein.
@en
P2093
Gheorghiu M
Lagranderie M
P356
10.1016/0378-1119(91)90587-2
P407
P577
1991-12-01T00:00:00Z